Sort
15,273 grants matching “antimicrobial resistance”
Project 1
$249,957Jyotika Sharma · University Of North Dakota · P20 · FY2016 · GM
INFECTION-RESISTANT POLYURETHANE MATERIALS
$249,951Cardiotech International, Inc. · R42 · FY2000 · HL
Synthesis of Lactonamycin and Related Polyketides
$249,910Seiichi P.t. Matsuda · Rice University · R01 · FY2006 · AI
Determinants and Mechanisms of Efficacy of Peptide Antibiotics as Novel Sepsis Therapy
$249,903Berthony Deslouches · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · GM
STAPH KERATITIS--MECHANISMS/ARRESTING OF CORNEAL DAMAGE
$249,898Louisiana State Univ Hsc New Orleans · R01 · FY2000 · EY
INFECTION-RESISTANT POLYURETHANE MATERIALS
$249,782Cardiotech International, Inc. · R42 · FY2001 · HL
Expanding the genetic code in Salmonella
$249,750Chenguang Fan · Yale University · R21 · FY2015 · AI
Trans-tympanic treatment of otitis media
$249,744Daniel S Kohane · Boston Children'S Hospital · R21 · FY2011 · DC
RFA-CK-22-008, Building Next-generation Mathematical Biology Modeling Workforce for HAI Control
$249,625Shi Chen · University Of North Carolina Charlotte · U01 · FY2022 · CK
A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers
$249,623Alexander H Flannery · University Of Kentucky · R21 · FY2023 · AI
Targetting InhA For Anti-TB Drug Discovery
$249,602Peter J Tonge · State University New York Stony Brook · R01 · FY2007 · AI
Function of the Sts protein phosphodiesterase domain
$249,595Jarrod B French · University Of Minnesota · R21 · FY2021 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$249,587Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2025 · AI
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
$249,480David J. Margolis · University Of Pennsylvania · R34 · FY2019 · AR
Selective eradication of nasopharyngeal colonization to prevent otitis media
$249,471Timothy F Murphy · State University Of New York At Buffalo · R21 · FY2014 · DC
Design of multi-target D-Ala-D-Ala ligase ligands
$249,426Judith Varady Hobrath · Southern Research Institute · R21 · FY2010 · AI
Development of Novel Bacteriophages Targeting Enteric Bacterial Pathogens
$249,312Christina S Faherty · Massachusetts General Hospital · R21 · FY2021 · AI
Spin-Labeled Peptide Antibiotics
$249,218Medical College Of Wisconsin · R01 · FY2005 · GM
Periplasmic Zinc Management and Homeostasis in Paracoccus denitrificans
$249,168Erik T Yukl · New Mexico State University Las Cruces · R01 · FY2018 · GM
A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection
$249,135Paul Michael Arnaboldi · New York Medical College · R21 · FY2022 · AI
Unleashing CD8+ T Cells for TB Defense
$249,085Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
The alternative roles of Neisseria CRISPR-Cas9 in endogenous gene regulation and bacterial physiology
$249,000Yan Zhang · University Of Michigan At Ann Arbor · R00 · FY2018 · GM
Role of sulfide in oral microbiota-host interactions that promote periodontitis
$249,000Apollo Stacy · Cleveland Clinic Lerner Com-Cwru · R00 · FY2023 · DE
Engineering a diagnostic platform for rapid breath-based respiratory pathogen identification and treatment monitoring
$249,000Leslie Chan · Georgia Institute Of Technology · R00 · FY2021 · EB
Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal Infection
$249,000Lauren Jo Delaney · Thomas Jefferson University · R00 · FY2023 · AR